Cargando…

A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda

INTRODUCTION: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Musoke, Phillip, Okot, Jerom, Nanfuka, Vivien, Rwamafa, Pius, Masajjage, Joseph, Kisuule, Ivan, Nantaayi, Brandy, Ssewante, Nelson, Bongomin, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594886/
https://www.ncbi.nlm.nih.gov/pubmed/34803412
http://dx.doi.org/10.2147/RMHP.S339408
_version_ 1784600078081589248
author Musoke, Phillip
Okot, Jerom
Nanfuka, Vivien
Rwamafa, Pius
Masajjage, Joseph
Kisuule, Ivan
Nantaayi, Brandy
Ssewante, Nelson
Bongomin, Felix
author_facet Musoke, Phillip
Okot, Jerom
Nanfuka, Vivien
Rwamafa, Pius
Masajjage, Joseph
Kisuule, Ivan
Nantaayi, Brandy
Ssewante, Nelson
Bongomin, Felix
author_sort Musoke, Phillip
collection PubMed
description INTRODUCTION: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda. METHODS: A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers’ exact test for categorical and Mann–Whitney U-test for numerical were used to determine the association between dependent and independent variables. RESULTS: The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range: 20–75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR): 3.1, 95% confidence interval (CI): 1.4–6.8, p = 0.005) and having attained tertiary level of education (aOR: 6.2, 95% CI: 1.7–23.1, p = 0.006), as well as the accessibility to herbalists (aOR: 31.2, 95% CI: 3.7–263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53). CONCLUSION: The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy.
format Online
Article
Text
id pubmed-8594886
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-85948862021-11-18 A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda Musoke, Phillip Okot, Jerom Nanfuka, Vivien Rwamafa, Pius Masajjage, Joseph Kisuule, Ivan Nantaayi, Brandy Ssewante, Nelson Bongomin, Felix Risk Manag Healthc Policy Original Research INTRODUCTION: Herbal medication use among patients with COVID-19 imposes a significant risk of drug-herbal interactions and adverse events. This study aimed to assess the prevalence and factors associated with herbal medicine use among patients hospitalized with COVID-19 attending two large COVID-19 Treatment Units (CTU) in Uganda. METHODS: A hospital-based descriptive cross-sectional study was conducted recruiting patients with COVID-19 hospitalized at the Mulago National Referral Hospital and Namboole Stadium CTUs. Chi-square or Fishers’ exact test for categorical and Mann–Whitney U-test for numerical were used to determine the association between dependent and independent variables. RESULTS: The study was terminated early because of significant reduction in the number of patients hospitalized with COVID-19 and the closure of Namboole CTU. Of the anticipated 422 participants, we recruited 108 (25.6%). Of this, 58 (53.7%) were female, with a median age of 38 (range: 20–75) years. Forty-nine (45.4%) had received at least one dose of the COVID-19 vaccine. Fifty-eight (57.3%) of the participants had ever used herbal medicine and the majority had used them in the past 12 months (71.9%, n = 41) either before the diagnosis of COVID-19 (85.4%, n = 35) or after (36.6%, n = 15). Being vaccinated for COVID-19 (adjusted odds ratio (aOR): 3.1, 95% confidence interval (CI): 1.4–6.8, p = 0.005) and having attained tertiary level of education (aOR: 6.2, 95% CI: 1.7–23.1, p = 0.006), as well as the accessibility to herbalists (aOR: 31.2, 95% CI: 3.7–263.2, p = 0.002) were significantly associated with herbal medication use. The majority of participants reported some improvement after using herbal medicine (80.7%, n = 46) and their doctors or nurses asked almost half of the participants about herbal medicine use (49.5%, n = 53). CONCLUSION: The use of herbal medicines to treat or prevent COVID-19 among hospitalized patients is a widespread practice in Uganda amidst unpublished evidence of their safety and efficacy. Dove 2021-11-12 /pmc/articles/PMC8594886/ /pubmed/34803412 http://dx.doi.org/10.2147/RMHP.S339408 Text en © 2021 Musoke et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Musoke, Phillip
Okot, Jerom
Nanfuka, Vivien
Rwamafa, Pius
Masajjage, Joseph
Kisuule, Ivan
Nantaayi, Brandy
Ssewante, Nelson
Bongomin, Felix
A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
title A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
title_full A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
title_fullStr A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
title_full_unstemmed A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
title_short A Preliminary Report on Herbal Medicine Use Among Patients Hospitalized at Two-Large COVID-19 Treatment Centers in Uganda
title_sort preliminary report on herbal medicine use among patients hospitalized at two-large covid-19 treatment centers in uganda
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594886/
https://www.ncbi.nlm.nih.gov/pubmed/34803412
http://dx.doi.org/10.2147/RMHP.S339408
work_keys_str_mv AT musokephillip apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT okotjerom apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT nanfukavivien apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT rwamafapius apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT masajjagejoseph apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT kisuuleivan apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT nantaayibrandy apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT ssewantenelson apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT bongominfelix apreliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT musokephillip preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT okotjerom preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT nanfukavivien preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT rwamafapius preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT masajjagejoseph preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT kisuuleivan preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT nantaayibrandy preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT ssewantenelson preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda
AT bongominfelix preliminaryreportonherbalmedicineuseamongpatientshospitalizedattwolargecovid19treatmentcentersinuganda